secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fuse Medical, Inc. (FZMD)
CIK:        0000319016
Form:       8-K
Filed at:   2023-08-15T23:59:59+00:00
Accession:  0001437749-23-023797
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fuse Medical Q2 2023 net income $307,588 vs loss of $322,936 a year ago
-----------------------------------------------------------------------

- Revenue rose 7% to $5.0M from $4.7M in Q2 2022.
- Gross profit grew 31% to $3.5M (69% margin) from $2.6M (57% margin).
- SG&A expense increased to $1.6M from $1.4M; commissions down slightly.
- EBITDA swung to $401,574 from a loss of $246,834 year-over-year.
- CEO cites growth from portfolio of Fuse branded/manufactured products and national distribution expansion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/319016/000143774923023797/0001437749-23-023797-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/319016/000143774923023797/fzmd20230808c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-023797

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer